Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus Interventions: Drug: TQ-F3083 capsule 5 mg; Drug: TQ-F3083 capsule 10 mg; Drug: TQ-F3083 blank analog capsule; Drug: Linagliptin blank analog tablet; Drug: Linagliptin tablet Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials